Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsies

American Journal of Gastroenterology

Volumn 103, Issue 9, 2008, Pages 2333-2340

  Downs Kelly, Erinn ^a   Mendelin, Joel E ^a   Bennett, Ana E ^a   Castilla, Elias ^a   Henricks, Walter H ^a   Schoenfield, Lynn ^a   Skacel, Marek ^a   Yerian, Lisa ^a   Rice, Thomas W ^a   Rybicki, Lisa A ^a   Bronner, Mary P ^a   Goldblum, John R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ARTICLE; BARRETT ESOPHAGUS; CANCER INVASION; CONTROLLED STUDY; DISEASE CLASSIFICATION; DYSPLASIA; ESOPHAGOSTOMY; ESOPHAGUS BIOPSY; HUMAN; HUMAN TISSUE; INTERRATER RELIABILITY; INTRARATER RELIABILITY; KAPPA STATISTICS; MEDICAL DECISION MAKING; METAPLASIA; PRIORITY JOURNAL; REPRODUCIBILITY;

ADENOCARCINOMA; BARRETT ESOPHAGUS; BIOPSY; ESOPHAGEAL NEOPLASMS; HUMANS; OBSERVER VARIATION; PRECANCEROUS CONDITIONS;

EID: 50649105290     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2008.02020.x     Document Type: Article

References (36)

1. Wang KK and Sampliner RE. Updated guidelines 2008 for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2008 103 : 788 97.
2. Reid BJ, Haggitt RC, Rubin CE, et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Human Pathol 1988 19 : 166 78.
3. Montgomery E, Bronner MP, Goldblum JR, et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Human Pathol 2001 32 : 368 78.
4. Schnell TG, Sontag SJ, Chejfec G, et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 2001 120 : 1607 19.
5. Shaheen NJ. Separating bad from worse in Barrett's esophagus. Gastroenterology 2003 125 : 260 1 discussion 261-2.
6. Odze RD. Diagnosis and grading of dysplasia in Barrett's oesophagus. J Clin Pathol 2006 59 : 1029 38.
7. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977 33 : 159 74.
8. Altman D. Practical statistics for medical research. New York : Chapman and Hall, 1991.
9. Montgomery E, Goldblum JR, Greenson JK, et al. Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: A follow-up study based on 138 cases from a diagnostic variability study. Human Pathol 2001 32 : 379 88.
10. Buttar NS, Wang KK, Sebo TJ, et al. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology 2001 120 : 1630 9.
11. Overholt BF, Lightdale CJ, Wang KK, et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: International, partially blinded, randomized phase III trial. Gastrointest Endosc 2005 62 : 488 98.
12. Reid BJ, Levine DS, Longton G, et al. Predictors of progression to cancer in Barrett's esophagus: Baseline histology and flow cytometry identify low- and high-risk patient subsets. Am J Gastroenterol 2000 95 : 1669 76.
13. Levine DS, Haggitt RC, Blount PL, et al. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 1993 105 : 40 50.
14. Reid BJ, Weinstein WM, Lewin KJ, et al. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology 1988 94 : 81 90.
15. Byrne JP, Armstrong GR, Attwood SE. Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulation. Am J Gastroenterol 1998 93 : 1810 5.
16. Barr H, Shepherd NA, Dix A, et al. Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX. Lancet 1996 348 : 584 5.
17. Overholt BF, Panjehpour M, Haydek JM. Photodynamic therapy for Barrett's esophagus: Follow-up in 100 patients. Gastrointest Endosc 1999 49 : 1 7.
18. Barham CP, Jones RL, Biddlestone LR, et al. Photothermal laser ablation of Barrett's oesophagus: Endoscopic and histological evidence of squamous re-epithelialisation. Gut 1997 41 : 281 4.
19. Ell C, May A, Gossner L, et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 2000 118 : 670 7.
20. Ell C, May A, Pech O, et al. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). Gastrointest Endosc 2007 65 : 3 10.
21. Haggitt RC, Reid BJ, Rabinovitch PS, et al. Barrett's esophagus. Correlation between mucin histochemistry, flow cytometry, and histologic diagnosis for predicting increased cancer risk. Am J Pathol 1988 131 : 53 61.
22. Reid BJ, Blount PL, Rubin CE, et al. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: Prospective endoscopic surveillance of a cohort. Gastroenterology 1992 102 : 1212 9.
23. Polkowski W, van Lanschot JJ, Ten Kate FJ, et al. The value of p53 and Ki67 as markers for tumour progression in the Barrett's dysplasia-carcinoma sequence. Surg Oncol 1995 4 : 163 71.
24. Skacel M, Petras RE, Rybicki LA, et al. p53 expression in low-grade dysplasia in Barrett's esophagus: Correlation with interobserver agreement and disease progression. Am J Gastroenterol 2002 97 : 2508 13.
25. Fahmy M, Skacel M, Gramlich TL, et al. Chromosomal gains and genomic loss of p53 and p16 genes in Barrett's esophagus detected by fluorescence in situ hybridization of cytology specimens. Mod Pathol 2004 17 : 588 96.
26. Sampliner RE. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 1998 93 : 1028 32.
27. Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002 97 : 1888 95.
28. Nijhawan PK, Wang KK. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett's esophagus. Gastrointest Endosc 2000 52 : 328 32.
29. Johnston MH. Cryotherapy and other newer techniques. Gastrointest Endosc Clin N Am 2003 13 : 491 504.
30. Overholt BF. Evaluating treatments of Barrett's esophagus that shows high-grade dysplasia. Am J Manag Care 2000 6 : S903 8.
31. Sampliner RE, Faigel D, Fennerty MB, et al. Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: A multicenter study. Gastrointest Endosc 2001 53 : 554 8.
32. Van Laethem JL, Cremer M, Peny MO, et al. Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: Immediate and mid term results. Gut 1998 43 : 747 51.
33. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983 14 : 931 66.
34. Ormsby AH, Petras RE, Henricks WH, et al. Observer variation in the diagnosis of superficial oesophageal adenocarcinoma. Gut 2002 51 : 671 6.
35. Mino-Kenudson M, Hull MJ, Brown I, et al. EMR for Barrett's esophagus-related superficial neoplasms offers better diagnostic reproducibility than mucosal biopsy. Gastrointest Endosc 2007 66 : 660 6 quiz 767, 9.
36. Haggitt RC. Barrett's esophagus, dysplasia, and adenocarcinoma. Human Pathol 1994 25 : 982 93.